ATF4 and neoplasm: Consistently, the administration of (−)-agelamide D alone did not affect xenograft tumor growth in nude mice but enhanced tumor growth inhibition in combination with RT, which correlated with an increase in ATF4 expression and apoptotic cells within tumors.